Integrated Immunology Cellomatics operates as an ISO-certified translational human cell-based preclinical CRO with in-house donor recruitment and advanced immunology capabilities, including flow cytometry, multiplex cytokine analysis and high-content imaging, enabling customized immunology assay services and biomarker validation to support drug discovery.

INNOBEX Growth The launch of INNOBEX and related platforms for Blood-Brain Barrier modeling, along with new tools for NASH and pulmonary fibrosis, creates cross-sell opportunities into CNS, liver and lung therapeutic programs and offers potential licensing or collaboration paths for pharma and biotech partners.

Global Credibility Recent awards and finalist recognition at Medilink Midlands and Go Global underscore credibility and signal readiness to collaborate with international clients, reducing perceived outsourcing risk for preclinical work.

Agile Partner With a compact team size and ISO-certified processes, Cellomatics can deliver flexible study design, rapid execution and highly customized translational research services, appealing to biotech startups and pharma seeking bespoke preclinical solutions.

Market Readiness The growing demand for physiologically relevant, predictive preclinical data aligns with Cellomatics focus on human cell-based models and high-content analytics, positioning the company to pursue biomarker validation, translational research collaborations and early drug discovery partnerships.